Lion Point Capital, LP 13F Holdings · Q2 2026
Lion Point Capital, LP reported 35 securities worth $20.91M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: CUE (7.99%), PRAX (7.13%), MLTX (6.29%). Among its top 25 positions this quarter: 1 new.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CUE | CUE BIOPHARMA INC | $1.7M | 7.99% | 52,928 | New |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | $1.5M | 7.13% | 4,450 | Hold |
| 3 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.3M | 6.29% | 67,500 | Hold |
| 4 | FENC | FENNEC PHARMACEUTICALS INC | $1.2M | 5.78% | 112,434 | Hold |
| 5 | RPRX | ROYALTY PHARMA PLC | $1.2M | 5.74% | 21,400 | Hold |
| 6 | CMPS | COMPASS PATHWAYS PLC | $1.1M | 5.41% | 80,000 | Hold |
| 7 | MIST | MILESTONE PHARMACEUTICALS IN | $1.1M | 5.26% | 820,000 | Hold |
| 8 | BNTC | BENITEC BIOPHARMA INC | $829,560 | 3.97% | 62,000 | Hold |
| 9 | SNDX | SYNDAX PHARMACEUTICALS INC | $786,960 | 3.76% | 36,000 | Hold |
| 10 | BHVN | BIOHAVEN LTD | $769,296 | 3.68% | 51,700 | Hold |
| 11 | GERN | GERON CORP | $739,840 | 3.54% | 578,000 | Hold |
| 12 | QURE | UNIQURE NV | $677,082 | 3.24% | 14,700 | Hold |
| 13 | ARDX | ARDELYX INC | $656,115 | 3.14% | 128,650 | Hold |
| 14 | LNTH | LANTHEUS HLDGS INC | $610,170 | 2.92% | 5,500 | Hold |
| 15 | IRON | DISC MEDICINE INC | $592,434 | 2.83% | 8,100 | Hold |
| 16 | SRPT | SAREPTA THERAPEUTICS INC | $512,145 | 2.45% | 28,500 | Hold |
| 17 | HUMA | HUMACYTE INC | $507,260 | 2.43% | 650,000 | Hold |
| 18 | KURA | KURA ONCOLOGY INC | $504,620 | 2.41% | 46,000 | Hold |
| 19 | VTRS | VIATRIS INC | $439,876 | 2.10% | 27,700 | Hold |
| 20 | DYN | DYNE THERAPEUTICS INC | $399,780 | 1.91% | 18,000 | Hold |
| 21 | BBIO | BRIDGEBIO PHARMA INC | $372,400 | 1.78% | 5,000 | Hold |
| 22 | EWTX | EDGEWISE THERAPEUTICS INC | $369,733 | 1.77% | 9,100 | Hold |
| 23 | PCRX | PACIRA BIOSCIENCES INC | $342,495 | 1.64% | 13,500 | Hold |
| 24 | RGNX | REGENXBIO INC | $318,668 | 1.52% | 26,600 | Hold |
| 25 | RCKT | ROCKET PHARMACEUTICALS INC | $294,120 | 1.41% | 86,000 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR